948 related articles for article (PubMed ID: 33109219)
1. Association between triglyceride glucose-body mass index and non-alcoholic fatty liver disease in the non-obese Chinese population with normal blood lipid levels: a secondary analysis based on a prospective cohort study.
Li Y; Zheng R; Li J; Feng S; Wang L; Huang Z
Lipids Health Dis; 2020 Oct; 19(1):229. PubMed ID: 33109219
[TBL] [Abstract][Full Text] [Related]
2. The triglyceride glucose-body mass index: a non-invasive index that identifies non-alcoholic fatty liver disease in the general Japanese population.
Hu H; Han Y; Cao C; He Y
J Transl Med; 2022 Sep; 20(1):398. PubMed ID: 36064712
[TBL] [Abstract][Full Text] [Related]
3. The usefulness of obesity and lipid-related indices to predict the presence of Non-alcoholic fatty liver disease.
Sheng G; Lu S; Xie Q; Peng N; Kuang M; Zou Y
Lipids Health Dis; 2021 Oct; 20(1):134. PubMed ID: 34629059
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of the triglyceride glucose-body mass index in evaluating nonalcoholic fatty liver disease: insights from a general population.
Wang R; Dai L; Zhong Y; Xie G
Lipids Health Dis; 2021 Jul; 20(1):77. PubMed ID: 34321005
[TBL] [Abstract][Full Text] [Related]
5. Triglyceride glucose-waist circumference: the optimum index to screen nonalcoholic fatty liver disease in non-obese adults.
Li S; Feng L; Ding J; Zhou W; Yuan T; Mao J
BMC Gastroenterol; 2023 Nov; 23(1):376. PubMed ID: 37919650
[TBL] [Abstract][Full Text] [Related]
6. Triglyceride glucose-body mass index is effective in identifying nonalcoholic fatty liver disease in nonobese subjects.
Zhang S; Du T; Li M; Jia J; Lu H; Lin X; Yu X
Medicine (Baltimore); 2017 Jun; 96(22):e7041. PubMed ID: 28562560
[TBL] [Abstract][Full Text] [Related]
7. Value of the triglyceride glucose index combined with body mass index in identifying non-alcoholic fatty liver disease in patients with type 2 diabetes.
Li N; Tan H; Xie A; Li C; Fu X; Xang W; Kirim A; Huang X
BMC Endocr Disord; 2022 Apr; 22(1):101. PubMed ID: 35428219
[TBL] [Abstract][Full Text] [Related]
8. Triglyceride Glucose Index and Related Parameters (Triglyceride Glucose-Body Mass Index and Triglyceride Glucose-Waist Circumference) Identify Nonalcoholic Fatty Liver and Liver Fibrosis in Individuals with Overweight/Obesity.
Khamseh ME; Malek M; Abbasi R; Taheri H; Lahouti M; Alaei-Shahmiri F
Metab Syndr Relat Disord; 2021 Apr; 19(3):167-173. PubMed ID: 33259744
[No Abstract] [Full Text] [Related]
9. Triglyceride glucose-body mass index and the risk of diabetes: a general population-based cohort study.
Wang X; Liu J; Cheng Z; Zhong Y; Chen X; Song W
Lipids Health Dis; 2021 Sep; 20(1):99. PubMed ID: 34488806
[TBL] [Abstract][Full Text] [Related]
10. Markers of insulin resistance associated with non-alcoholic fatty liver disease in non-diabetic population.
Zeng P; Cai X; Yu X; Gong L
Sci Rep; 2023 Nov; 13(1):20470. PubMed ID: 37993481
[TBL] [Abstract][Full Text] [Related]
11. Non-alcoholic fatty liver disease in Tanzania: prevalence, determinants, and diagnostic performance of triglycerides-glucose index and triglycerides-glucose index -body mass index compared to the hepatic ultrasound in overweight and obese individuals.
Kilonzo SB; Kamala E; Jaka H; Ngoya P
BMC Gastroenterol; 2024 Mar; 24(1):96. PubMed ID: 38438930
[TBL] [Abstract][Full Text] [Related]
12. A non-linear relationship between triglyceride glucose waist circumference and nonalcoholic fatty liver disease in a Japanese population: a secondary analysis.
He X; Huang X; Qian Y; Sun T
Front Endocrinol (Lausanne); 2023; 14():1188214. PubMed ID: 37484966
[TBL] [Abstract][Full Text] [Related]
13. The Triglyceride and Glucose Index Is a Predictor of Incident Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study.
Kitae A; Hashimoto Y; Hamaguchi M; Obora A; Kojima T; Fukui M
Can J Gastroenterol Hepatol; 2019; 2019():5121574. PubMed ID: 31687367
[TBL] [Abstract][Full Text] [Related]
14. Utility of Indices Obtained during Medical Checkups for Predicting Fatty Liver Disease in Non-obese People.
Otsubo N; Fukuda T; Cho G; Ishibashi F; Yamada T; Monzen K
Intern Med; 2023 Aug; 62(16):2307-2319. PubMed ID: 36517035
[TBL] [Abstract][Full Text] [Related]
15. The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease.
Zhang S; Du T; Zhang J; Lu H; Lin X; Xie J; Yang Y; Yu X
Lipids Health Dis; 2017 Jan; 16(1):15. PubMed ID: 28103934
[TBL] [Abstract][Full Text] [Related]
16. Baseline level and change trajectory of the triglyceride-glucose index in relation to the development of NAFLD: a large population-based cohort study.
Wang Y; Wang J; Liu L; Yang P; Deng S; Liu X; Zhao L; Wang C; Li Y
Front Endocrinol (Lausanne); 2023; 14():1137098. PubMed ID: 37223043
[TBL] [Abstract][Full Text] [Related]
17. Relationship between triglyceride glucose index and the incidence of non-alcoholic fatty liver disease in the elderly: a retrospective cohort study in China.
Huanan C; Sangsang L; Amoah AN; Yacong B; Xuejiao C; Zhan S; Guodong W; Jian H; Songhe S; Quanjun L
BMJ Open; 2020 Nov; 10(11):e039804. PubMed ID: 33247011
[TBL] [Abstract][Full Text] [Related]
18. Fatty liver biomarkers and insulin resistance indices in the prediction of non-alcoholic fatty liver disease in Ghanaian patients.
Bockarie AS; Nartey YA; Nsiah P; Edzie EKM; Tuoyire D; Acquah S; Eliason S; Nkum B
Endocrinol Diabetes Metab; 2023 Nov; 6(6):e456. PubMed ID: 37814510
[TBL] [Abstract][Full Text] [Related]
19. Correlation between triglyceride glucose-body mass index and hypertension risk: evidence from a cross-sectional study with 60,283 adults in eastern China.
Chen Y; Du J; Zhou N; Song Y; Wang W; Hong X
BMC Cardiovasc Disord; 2024 May; 24(1):270. PubMed ID: 38783200
[TBL] [Abstract][Full Text] [Related]
20. Elevated triglyceride-glucose (TyG) index predicts incidence of Prediabetes: a prospective cohort study in China.
Wen J; Wang A; Liu G; Wang M; Zuo Y; Li W; Zhai Q; Mu Y; Gaisano HY; He Y; Dou J
Lipids Health Dis; 2020 Oct; 19(1):226. PubMed ID: 33059672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
